Skip to main content

Table 1 Clinical characteristics and radiotherapy details

From: Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study

Characteristics

Value

Age (years)

Median (range)

68 (52–79*)

PSA (ng/ml)

Median (range)

7,7 (0.5–25)

Gleason score (n)

6

56

7

10

8

2

T stage (n)

T1c

47

T2

21

RT technique (n)

3DCRT

66

VMAT/IMRT

2

  1. *2 patients were included at age 76 and 79 but in those cases the study team
  2. approved to continue with study treatment as planned
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us